Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Crespo

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Scientific Reports|April 30, 2026
Management and outcomes of infective endocarditis in a community hospital and its cardiac surgery referral centreBelen Jufresa-Michavila, Cristina Bayés-Ricart, Sara Grillo, et al.
Cells|November 8, 2018
Dysregulation of the Immune System in HIV/HCV-Coinfected Patients According to Liver Stiffness StatusPilar Garcia-Broncano, Luz Maria Medrano, Juan Berenguer, et al.
Scientific Reports|August 23, 2019
Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVRLorena Vigón, Sonia Vázquez-Morón, Juan Berenguer, et al.
The Journal of Infection|December 6, 2011
Hepatic safety of efavirenz in HIV/hepatitis C virus-coinfected patients with advanced liver fibrosisJuan A Pineda, Karin Neukam, Josep Mallolas, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 28, 2017
Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up studyJose Sanchez-Moreno, Caterina Bonnín, Ana González-Pinto, et al.
Journal of the International AIDS Society|November 15, 2014
ACTG-HIV symptoms changes in patients switched to RPV/FTC/TDF due to previous intolerance to CART. Interim analysis of the PRO-STR studyDaniel Podzamczer, Nerea Rozas, Pere Domingo, et al.
The Journal of Infectious Diseases|July 1, 2020
Massive Release of CD9+ Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic ControlEva Poveda, Andrés Tabernilla, Wendy Fitzgerald, et al.
European Journal of Immunology|October 16, 2015
Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cellsNicola Ternette, Hongbing Yang, Thomas Partridge, et al.
Microorganisms|November 27, 2021
Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1β, Early Predictors of Severe COVID-19Helena Codina, Irene Vieitez, Alicia Gutierrez-Valencia, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 11, 2024
The diagnostic accuracy of HE4 in the differential diagnosis of pleural effusionsSilvia Bérgamo, Jaume Trapé, Laura González-García, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Scientific Reports|April 30, 2026
Management and outcomes of infective endocarditis in a community hospital and its cardiac surgery referral centreBelen Jufresa-Michavila, Cristina Bayés-Ricart, Sara Grillo, et al.
Cells|November 8, 2018
Dysregulation of the Immune System in HIV/HCV-Coinfected Patients According to Liver Stiffness StatusPilar Garcia-Broncano, Luz Maria Medrano, Juan Berenguer, et al.
Scientific Reports|August 23, 2019
Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVRLorena Vigón, Sonia Vázquez-Morón, Juan Berenguer, et al.
The Journal of Infection|December 6, 2011
Hepatic safety of efavirenz in HIV/hepatitis C virus-coinfected patients with advanced liver fibrosisJuan A Pineda, Karin Neukam, Josep Mallolas, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 28, 2017
Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up studyJose Sanchez-Moreno, Caterina Bonnín, Ana González-Pinto, et al.
Journal of the International AIDS Society|November 15, 2014
ACTG-HIV symptoms changes in patients switched to RPV/FTC/TDF due to previous intolerance to CART. Interim analysis of the PRO-STR studyDaniel Podzamczer, Nerea Rozas, Pere Domingo, et al.
The Journal of Infectious Diseases|July 1, 2020
Massive Release of CD9+ Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic ControlEva Poveda, Andrés Tabernilla, Wendy Fitzgerald, et al.
European Journal of Immunology|October 16, 2015
Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cellsNicola Ternette, Hongbing Yang, Thomas Partridge, et al.
Microorganisms|November 27, 2021
Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1β, Early Predictors of Severe COVID-19Helena Codina, Irene Vieitez, Alicia Gutierrez-Valencia, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 11, 2024
The diagnostic accuracy of HE4 in the differential diagnosis of pleural effusionsSilvia Bérgamo, Jaume Trapé, Laura González-García, et al.
Pageof 12